hydroxyurea has been researched along with Schistosomiasis mansoni in 2 studies
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eldeeb, E | 1 |
| Fahmy, S | 1 |
| Elbakry, K | 1 |
| Hyder, A | 1 |
| Lopes, LM | 1 |
| Pereira, MA | 1 |
| Gerken, SE | 1 |
| Vaz, N | 1 |
2 other studies available for hydroxyurea and Schistosomiasis mansoni
| Article | Year |
|---|---|
A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Female; | 2018 |
Polyclonal activation of B lymphocytes during experimental infection with Schistosoma mansoni.
Topics: Animals; Antigens, Helminth; B-Lymphocytes; Chagas Disease; Hydroxyurea; Immunity, Cellular; Immuniz | 1990 |